The Liver Meeting 2019-Non-alcoholic Fatty Liver Disease: Non-invasive Phenotyping

Non-alcoholic Fatty Liver Disease: Non-invasive Phenotyping

Video Transcription

Video Summary

The 52-year-old female with type 2 diabetes had an abdominal ultrasound showing fatty liver. The patient had elevated liver chemistry tests and a history of diabetes, hypertension, and hypothyroidism. Factors like ethnicity and genetic markers play a role in disease progression. Non-invasive tests like NAFL fibrosis score can assess liver health. Liver stiffness evaluation helps in predicting fibrosis and assessing risk. Biomarkers and imaging techniques are evolving for NASH diagnosis and predicting outcomes. Liver biopsy remains crucial for management decisions. Lifestyle interventions, medications, or bariatric surgery may be recommended based on findings. Understanding the dynamic nature of fatty liver disease and its impact on liver health is important for patient care and prognosis.

Asset Caption

Presenter: Mary Rinella

Keywords

type 2 diabetes

fatty liver

NAFL fibrosis score

NASH diagnosis

liver biopsy